Michael Günther

8PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersPhysical organic chemistryMulticultural education (excl. Aboriginal and Torres Strait Islander, Māori and Pacific Peoples)Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 01, 2026
TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancer.

|Mar 10, 2026
Multi-omic profiling defines three distinct molecular subtypes of urothelial carcinoma with implications for precision therapy.

Nils C H van Creij, Piotr Tymoszuk, Florian Handle

|Jan 13, 2026

Steffen Ormanns, Andrea Brunner-Véber, Michael Günther

|Nov 13, 2025
[Residents training in Austria and Germany : Cross-border perspectives: career paths and opportunities].

Steffen Ormanns, Andrea Brunner-Véber, Michael Günther

|Sep 25, 2025
A distinct population of CD8+ T cells expressing CD39 and CD73 accumulates with age and supports cancer progression.

Monica Bodogai, Bongsoo Park, Fatima-Zohra Braikia

|Jun 10, 2025
Intratumoral bacterial abundance confers poor response to adjuvant gemcitabine in resected pancreatic cancer patients which is mitigated by postoperative antibiotics.

Michael Guenther, Sai Agash Surendran, Nina Hauer

Pageof 2

Frequent Collaborators

7 joint publications

Steffen Ormanns

1 joint publications

Kathrin Heinrich

1 joint publications

Frederick Klauschen

1 joint publications

Wolfgang G Kunz